Loading…

Synthesis and characterization of the antitubercular phenazine lapazine and development of PLGA and PCL nanoparticles for its entrapment

The aim of this work was to develop and characterize nanoparticles as carriers of lapazine, a phenazine derived from β-lapachone; its antimycobacterial activity is described for the first time as a potential treatment for tuberculosis. The lapazine was synthesized, and by using gas chromatography co...

Full description

Saved in:
Bibliographic Details
Published in:Materials Science & Engineering C 2016-01, Vol.58, p.458-466
Main Authors: Silveira, Narjara, Longuinho, Mariana M., Leitão, Suzana G., Silva, Raphael S.F., Lourenço, Maria C., Silva, Pedro E.A., Pinto, Maria do Carmo F.R., Abraçado, Leida G., Finotelli, Priscilla V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this work was to develop and characterize nanoparticles as carriers of lapazine, a phenazine derived from β-lapachone; its antimycobacterial activity is described for the first time as a potential treatment for tuberculosis. The lapazine was synthesized, and by using gas chromatography coupled to a flame ionization detector, it was possible to evaluate its purity degree of almost 100%. For better elucidation of the molecular structure, mass spectroscopy and 1H NMR were carried out and compared to the literature values. Lapazine was assayed in vitro against H37Rv Mycobacterium tuberculosis and a rifampicin-resistant strain, with minimum inhibitory concentration values of 3.00 and 1.56μgmL−1, respectively. The nanoparticles showed a polydispersity index of 0.16, mean diameter of 188.5±1.7mm, zeta potential of −15.03mV, and drug loading of 54.71mgg−1 for poly-ε-caprolactone (PCL) nanoparticles and a polydispersity index of 0.318, mean diameter of 197.4±2.7mm, zeta potential of −13.43mV and drug loading of 137.07mgg−1 for poly(dl-lactide-co-glycolide) (PLGA) nanoparticles. These results indicate that both polymeric formulations have good characteristics as potential lapazine carriers in the treatment of tuberculosis. [Display omitted] •Lapazine has activity against M. tuberculosis, but its lipophilicity restricts in vivo toxicity tests.•Two polymeric nanoparticle systems are proposed for lapazine entrapment.•Polymeric nanoparticles were characterized according to their physical, physical-chemistry properties and release profile.
ISSN:0928-4931
1873-0191
DOI:10.1016/j.msec.2015.08.062